Alpha DNA Investment Management’s Centene CNC Stock Holding History

Alpha DNA Investment Management’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,030	Closed	-$1.15M	–	180
2023 Q2	$1.15M	Buy	+17,030	New	+$1.14M	0.38%	46
2022 Q4	–	Sell	-9,064	Closed	-$705K	–	157
2022 Q3	$705K	Sell	9,064 -6,416	-41%	-$573K	0.59%	62
2022 Q2	$1.31M	Buy	+15,480	New	+$1.29M	1.12%	4
2021 Q2	–	Sell	-5	Closed	–	–	204
2021 Q1	$0	Hold	5	–	–	﹤0.01%	697
2020 Q4	$0	Buy	+5	New	+$318	﹤0.01%	595

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Alpha DNA Investment Management's CNC Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Centene (CNC) in Q3 2023, closing a stake of 17,030 shares — an estimated $1.15M sold.

Alpha DNA Investment Management first reported a position in CNC in Q4 2020 and held it in 5 quarters. The position peaked at $1.31M in Q2 2022. 823 funds tracked by Wall St. Rank hold CNC as of Q3 2023.

Alpha DNA Investment Management reported no remaining Centene position as of Q3 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 17,030 Centene shares in Q3 2023, an estimated $1.15M.
Alpha DNA Investment Management first reported a position in Centene in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's Centene position peaked at $1.31M in Q2 2022.
823 funds tracked by Wall St. Rank held Centene as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.